Literature DB >> 18925304

The impact of preoperative endoscopic ultrasound on the surgical management of pancreatic neuroendocrine tumours.

Fahad Alsohaibani1, David Bigam, Norman Kneteman, A M James Shapiro, Gurpal Singh Sandha.   

Abstract

BACKGROUND: Endoscopic ultrasound (EUS) is accurate in diagnosing pancreatic neuroendocrine tumours (PNETs), but its impact on surgical management is unclear.
OBJECTIVE: To determine whether preoperative EUS findings altered the decision for, and extent of, surgery in patients with PNETs.
METHODS: A retrospective review of patients referred for EUS because of suspected PNETs was conducted. The diagnosis of PNETs was confirmed by EUS-guided fine needle aspiration cytology, where indicated, or by surgical histology. EUS findings were compared with computed tomography (CT) findings to determine whether there was an impact on the decision for surgical management.
RESULTS: Fourteen patients (10 women), with a mean age of 44 years, underwent EUS for suspected PNETs. PNETs were seen with CT in 10 of 13 patients (77%) and with EUS in 14 of 14 patients (100%). One obese patient could not fit into the CT scanner. This patient had five PNETs on EUS. Three patients with a normal CT scan were determined to have one or two PNETs on EUS. Three patients with one or two PNETs on CT were found to have five to eight PNETs on EUS. EUS altered the decision for possible surgical management in five of 14 patients (36%), either by identifying a PNET or by finding multiple and multifocal PNETs that were not visualized on CT scans.
CONCLUSION: EUS is useful in the preoperative assessment of PNETs by providing information that significantly influences the decision for surgical intervention or changes the extent of the planned surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18925304      PMCID: PMC2661300          DOI: 10.1155/2008/868369

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  24 in total

1.  The impact of endoscopic ultrasonography on the management of suspected pancreatic cancer--a comprehensive longitudinal continuous evaluation.

Authors:  Jesse Lachter; Jonathan J Cooperman; Moshe Shiller; Alain Suissa; Kamel Yassin; Hector Cohen; Ron Reshef
Journal:  Pancreas       Date:  2007-08       Impact factor: 3.327

Review 2.  Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information.

Authors:  M R Wick; F M Graeme-Cook
Journal:  Am J Clin Pathol       Date:  2001-06       Impact factor: 2.493

3.  Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity.

Authors:  R F Thoeni; U G Mueller-Lisse; R Chan; N K Do; P B Shyn
Journal:  Radiology       Date:  2000-02       Impact factor: 11.105

Review 4.  Imaging of neuroendocrine tumours (CT/MR/US).

Authors:  Andrea G Rockall; Rodney H Reznek
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2007-03       Impact factor: 4.690

5.  Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas.

Authors:  M A Anderson; S Carpenter; N W Thompson; T T Nostrant; G H Elta; J M Scheiman
Journal:  Am J Gastroenterol       Date:  2000-09       Impact factor: 10.864

6.  MRI of pancreatic neuroendocrine tumours.

Authors:  N J Owen; S A Sohaib; P D Peppercorn; J P Monson; A B Grossman; G M Besser; R H Reznek
Journal:  Br J Radiol       Date:  2001-10       Impact factor: 3.039

7.  Is the new classification of neuroendocrine pancreatic tumors of clinical help?

Authors:  M Schindl; K Kaczirek; K Kaserer; B Niederle
Journal:  World J Surg       Date:  2000-11       Impact factor: 3.352

8.  EUS-guided FNA diagnosis of pancreatic endocrine tumors: new trends identified.

Authors:  Niraj Jani; Asif Khalid; Neeraj Kaushik; Debra Brody; Kathy Bauer; Karen Schoedel; N Paul Ohori; A James Moser; Kenneth Lee; Kevin McGrath
Journal:  Gastrointest Endosc       Date:  2008-01       Impact factor: 9.427

Review 9.  Pancreatic endocrine tumors.

Authors:  Niraj Jani; A James Moser; Asif Khalid
Journal:  Gastroenterol Clin North Am       Date:  2007-06       Impact factor: 3.806

10.  EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia.

Authors:  Erik-Jan Wamsteker; Paul G Gauger; Norman W Thompson; James M Scheiman
Journal:  Gastrointest Endosc       Date:  2003-10       Impact factor: 9.427

View more
  4 in total

1.  EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience.

Authors:  Muslim Atiq; Manoop S Bhutani; Mehmet Bektas; Jeffrey E Lee; Yun Gong; Eric P Tamm; Chintan P Shah; William A Ross; James Yao; Gottumukkala S Raju; Xuemei Wang; Jeffrey H Lee
Journal:  Dig Dis Sci       Date:  2011-10-01       Impact factor: 3.199

Review 2.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

Review 3.  Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Jessica E Maxwell; Thomas M O'Dorisio; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2015-10-31       Impact factor: 3.495

4.  Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franco Grimaldi; Nicola Fazio; Roberto Attanasio; Andrea Frasoldati; Enrico Papini; Francesco Angelini; Roberto Baldelli; Debora Berretti; Sara Bianchetti; Giancarlo Bizzarri; Marco Caputo; Roberto Castello; Nadia Cremonini; Anna Crescenzi; Maria Vittoria Davì; Angela Valentina D'Elia; Antongiulio Faggiano; Stefano Pizzolitto; Annibale Versari; Michele Zini; Guido Rindi; Kjell Oberg
Journal:  J Endocrinol Invest       Date:  2014-07-20       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.